http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120036813-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 |
filingDate | 2010-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c02ba0fe0fd2ef1a08901633ba4961c6 |
publicationDate | 2012-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20120036813-A |
titleOfInvention | New pharmaceutical compositions for the prevention and / or treatment of attention deficits / dynamic disorders |
abstract | It is an object of the present invention to provide a therapeutic agent for attention deficits / dynamic disorders having a novel mechanism of action different from conventional central stimulants. The present invention is useful as providing a pharmaceutical composition for the prevention and / or treatment of excellent attention deficits / multiple disorders, which contains a BEC1 potassium channel inhibitor or a pharmaceutically acceptable salt thereof as an active ingredient. It is particularly useful as providing a pharmaceutical composition for the prevention and / or treatment of carelessness, impulsivity, multiness and the like in a disorder. |
priorityDate | 2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.